FDA Moving Toward PAT Standardized Nomenclature And Definitions
This article was originally published in The Pink Sheet Daily
Executive Summary
The process analytical technology component of FDA's drug quality initiative will be assisted by an independent standards-making effort and agency encouragement of comparability protocols. Part 11 and dispute resolution are other quality initiative components drawing industry input.